- Home
- TEVA vs KEY Comparison
TEVA vs KEY Comparison
Compare TEVA & KEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- KEY
- Stock Information
- Founded
- TEVA 1901
- KEY 1825
- Country
- TEVA Israel
- KEY United States
- Employees
- TEVA N/A
- KEY 17406
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- KEY Major Banks
- Sector
- TEVA Health Care
- KEY Finance
- Exchange
- TEVA Nasdaq
- KEY Nasdaq
- Market Cap
- TEVA 18.4B
- KEY 17.3B
- IPO Year
- TEVA N/A
- KEY N/A
- Fundamental
- Price
- TEVA $16.77
- KEY $15.85
- Analyst Decision
- TEVA Strong Buy
- KEY Buy
- Analyst Count
- TEVA 7
- KEY 19
- Target Price
- TEVA $25.14
- KEY $18.95
- AVG Volume (30 Days)
- TEVA 14.1M
- KEY 12.5M
- Earning Date
- TEVA 05-07-2025
- KEY 07-21-2025
- Dividend Yield
- TEVA N/A
- KEY 5.17%
- EPS Growth
- TEVA N/A
- KEY N/A
- EPS
- TEVA N/A
- KEY N/A
- Revenue
- TEVA $16,616,000,000.00
- KEY $4,464,000,000.00
- Revenue This Year
- TEVA $5.69
- KEY $74.95
- Revenue Next Year
- TEVA N/A
- KEY $6.35
- P/E Ratio
- TEVA N/A
- KEY N/A
- Revenue Growth
- TEVA 3.82
- KEY N/A
- 52 Week Low
- TEVA $12.47
- KEY $12.73
- 52 Week High
- TEVA $22.80
- KEY $20.04
- Technical
- Relative Strength Index (RSI)
- TEVA 51.29
- KEY 52.89
- Support Level
- TEVA $16.68
- KEY $15.28
- Resistance Level
- TEVA $18.28
- KEY $16.08
- Average True Range (ATR)
- TEVA 0.63
- KEY 0.32
- MACD
- TEVA -0.04
- KEY -0.06
- Stochastic Oscillator
- TEVA 20.11
- KEY 39.86
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About KEY KeyCorp
With assets of over $185 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.